These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 5275880)
1. [Combined splenic scintigraphy and function test: a new differential diagnostic criterion in chronic myeloid leukemia and myelofibrosis]. Roux A; Fischer J; León A; Wolf R Verh Dtsch Ges Inn Med; 1969; 75():510-3. PubMed ID: 5275880 [No Abstract] [Full Text] [Related]
2. [Comparative splenogram data in patients with idiopathic myelofibrosis and chronic myeloleukosis]. Klimova NF; Shel'gas LE; Shitikova MG Lab Delo; 1968; 9():544-7. PubMed ID: 4184958 [No Abstract] [Full Text] [Related]
3. [A "myeloproliferative syndrome" of long duration (author's transl)]. Kühböck J; Peskar BM; Vormittag W Med Klin; 1974 Mar; 69(10):423-6. PubMed ID: 4524608 [No Abstract] [Full Text] [Related]
4. Significance of spleen pickup of radioactive gold-198. Verdon TA; Barrett O; Panettiere F J Nucl Med; 1967 May; 8(5):402. PubMed ID: 5230984 [No Abstract] [Full Text] [Related]
5. [Hypersplenism. What it is and what not]. Fischer J Internist (Berl); 1971 Apr; 12(4):176-86. PubMed ID: 4928640 [No Abstract] [Full Text] [Related]
8. [Value of combined splenic scintigraphy and function test in the evaluation of therapeutic measures in hematologic-oncologic diseases]. Fischer J; Junkert U; León A; Roux A Verh Dtsch Ges Inn Med; 1969; 75():507-10. PubMed ID: 5400189 [No Abstract] [Full Text] [Related]
11. Chronic myelogenous leukemia with myelofibrosis. Four years after auto-immune hemolytic anemia. Cohen SM Arch Intern Med; 1967 Jun; 119(6):620-5. PubMed ID: 5229776 [No Abstract] [Full Text] [Related]
12. Agnogenic myeloid metaplasia. Block M Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643 [No Abstract] [Full Text] [Related]
13. [Physiopathological and cytogenetic investigations of a case of myelofibrosis treated successfully with androgens]. Pileri A; Masera P; Pegoraro L; Gavosto F Haematologica; 1966; 51(1):57-72. PubMed ID: 4956677 [No Abstract] [Full Text] [Related]
14. [Characteristics of the course of myelocytic leukemia associated with myelofibrosis]. Klimova NF; Zakharova AV; Korenevskaia MI; Aksenova OV Probl Gematol Pereliv Krovi; 1975 Feb; 20(2):26-9. PubMed ID: 1059075 [No Abstract] [Full Text] [Related]
15. Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis. Lahtinen R; Lahtinen T; Romppanen T J Nucl Med; 1982 Mar; 23(3):218-24. PubMed ID: 6950031 [TBL] [Abstract][Full Text] [Related]
16. [Content of reduced glutathione in the erythrocytes of idiopathic myelofibrosis and chronic myeloleukemia patients]. Sorokin EM Lab Delo; 1980; (2):112-4. PubMed ID: 6153414 [No Abstract] [Full Text] [Related]
17. The differential diagnostic significance of bone-marrow biopsy in haemoblastoses. Nagy G; Krasznai G; Léhi M; Szegedi J Acta Morphol Acad Sci Hung; 1973; 21(1):79-88. PubMed ID: 4517967 [No Abstract] [Full Text] [Related]
18. [Isotopic studies as a guide for splenectomy in myeloid metaplasia with myelofibrosis (author's transl)]. Celada A; Laso FJ; Rudolf H; Herreros V; Donath A Sangre (Barc); 1977; 22(3):294-303. PubMed ID: 867208 [No Abstract] [Full Text] [Related]
19. [Chronic myeloid leukemia and osteomyelosclerosis--2 different diseases?]. Fischer W; Fölsch E Dtsch Med Wochenschr; 1975 May; 100(18):1025-8. PubMed ID: 1055674 [No Abstract] [Full Text] [Related]